Skip to main content
Caplight Logo









Enzymaster

Enzymaster

Private
NingboHealthcare & Life Scienceshttp://www.enzymaster.com/

Last Round

Series C

May 12, 2022

Total Funding Raised

$52.5M

Company Overview

Enzymaster is a biotechnology company that provides biocatalysis solutions. The company specializes in enzyme and strain-related catalysis technology, including enzyme evolution, strain modification, enzyme fermentation, and industrial production, serving sectors such as pharmaceutical engineering, fine chemicals, new materials, and environmental protection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

enzyme engineeringbiocatalysis servicescustom enzymesCDMOCROdirected evolutionprotein engineeringenzyme manufacturingenzymatic process developmentsynthetic biologysynbiocomputational enzyme designgreen chemistrycontract manufacturingAPI intermediatesfine chemicalsfermentation services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enzymaster Comparables

Compare Enzymaster with similar companies based on industry and business-model similarity.

Enzymaster comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
弈柯莱生物科技(集团)股份有限公司
83%
Codexis
82%
Huili Bio
81%

Enzymaster Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMay 12, 2022
Series BOct 19, 2020
Series AJan 31, 2018

Enzymaster Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors increased 816% MoM, reaching 1.1K.

  • Jun 1, 2025

    Monthly visitors grew 363% MoM, from 40 to 185.

Enzymaster Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Enzymaster Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Enzymaster's valuation, stock price, and market status.

Firmographic Details

HeadquartersNingbo
Employee Range2
Year Founded2013
Last FundingMay 12, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?